2016年5月25日

Success Stories: Premium Processing Allows Visiting Associate in the Field of Pharmacology to Receive EB-1A Petition Approval in 8 Days


Client’s Testimonial:
“Thank you so much and I am so appreciative for all your help and support with my I-140 petition.”

On March 3rd, 2016, we received another EB-1A (Alien of Extraordinary Ability) approval for a Visiting Associate in the Field of Pharmacology (Approval Notice).

 
 
 
General Field: Pharmacology
Position at the Time of Case Filing: Visiting Associate
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Maryland
Approval Notice Date: March 3rd, 2016
Processing Time: 7 days (Premium Processing Requested)


 
Case Summary:
A visiting associate approached North America Immigration Law Group (WeGreened.com) for help—he wanted to attain green cards for himself and his family. Our client’s EB-1A petition was approved in merely eight days thanks to Premium Processing (PP). Although the USCIS charges more for petitions filed under PP, they have to rapidly take action on the case within 15 days as opposed to the regular 4-9 months. We have no doubt that the combination of our meticulous EB1A presentation and our client’s strong credentials played an essential role in the case approval. Here are some of the things our legal team included in our EB-1A petition packet:
  • Publication Record: Our client had 49 peer-reviewed scientific articles and one book chapter to his name at the time of filing.
  • Citation Count: When we filed the case, our client’s work had gathered an impressive 892 citations.
  • Peer Review Experience: As an active and well-respected member of the scientific community, our client has conducted almost two dozen peer reviews for multiple high impact journals.
  • Research Efforts: Our client has extensive experience in the field of pharmacology and is researching the development of novel drug delivery systems and the creation of advanced quality control systems for the monitoring of these newly developed dosage forms. As part of our legal services, we demonstrated that our client’s original research significantly impacts the pharmaceutical and medical sectors in the United States.
  • Recommendation Letters: A strong as our client’s credentials were, we needed more support to strengthen our case. We persuaded our client to obtain recommendation letters from other influential members of his field. Five expert pharmacologists furnished us with recommendation letters, which verified our argument that our client’s work is important to the entire field. One of our client’s recommenders described our client as: “…a leader in pharmaceutical research. As few others possess similar levels of expertise, [Client’s] research will continue to be in high demand through the coming years.”
This EB-1A approval is another encouraging outcome of our law firm’s ability to help our clients attain green cards. We are currently helping our client prepare I-485 applications for himself and his family. We look forward to helping them with the final portion of the green card journey, and we thank our client for selecting us to help him attain green card success.